HighField Biopharmaceuticals ASCO 2024 Poster Presentation Shows HFK1, a Unique Immunoliposome May Improve Clinical Outcomes over Antibody Drug Conjugates
HFK1 is the company’s groundbreaking drug encapsulated immunoliposome for solid tumors with HER2 low expression…